Brief: SciVision Biotech receives EU patent
07/04/2017 09:17
April 7 (Reuters) - SciVision Biotech Inc 1786.TW :
* Says it receives EU patent for method for producing
cross-linked hyaluronic acid
Source text in Chinese: https://goo.gl/QlFCJd
Further company coverage: 1786.TW
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724;
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))
Recent news on Scivision Biotech
See all newsBrief: SciVision Biotech says 2017 dividend record date is June 23
Brief: SciVision Biotech scraps issuance plan of 1st overseas secured convertible corporate bonds
Brief: SciVision Biotech receives EU patent
Brief: SciVisison Biotech says no dividend for 2016
Brief: SciVision Biotech gets third category of medical materials sales license from TFDA for its products used for obstetrics and gynecology and urology